Stock Watch: Reaction To Pharma’s Q2 Earnings Remains Mixed

 
• By Andy Smith

Binary reactions continued in the second week of the earnings season as AstraZeneca and Sanofi unveiled their financials. This time, the performance of co-marketed products and differing exposures to China were possible culprits.

Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Business